SEC Filing Summary

August J. Troendle, President & CEO of Medpace Holdings, Inc., reported the sale of 16,083 shares of common stock on September 23, 2026, at a weighted average price of $628.64 per share. These shares were sold in multiple transactions ranging from $620.00 to $637.48. On September 24, 2026, Troendle reported the sale of an additional 27,833 shares of common stock at a weighted average price of $621.33 per share. These transactions were executed through limit orders during an open window period. Following these transactions, Troendle directly owns 389,456 shares. Additionally, 4,733,019 shares are held indirectly through Medpace Investors, LLC, with Troendle having sole voting and investment control over these shares.